114 related articles for article (PubMed ID: 38474453)
21. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
[TBL] [Abstract][Full Text] [Related]
22. [Atractylenolide I Can Induce Apoptosis of U266 Cells and Enhance Bortezomib Effect].
Mai ZX; Yu TQ; Fan TT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):177-184. PubMed ID: 32027273
[TBL] [Abstract][Full Text] [Related]
23. Effects of N-[N-(3, 5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells.
Mori M; Miyamoto T; Yakushiji H; Ohno S; Miyake Y; Sakaguchi T; Hattori M; Hongo A; Nakaizumi A; Ueda M; Ohno E
Hum Cell; 2012 Mar; 25(1):9-15. PubMed ID: 22189483
[TBL] [Abstract][Full Text] [Related]
24. Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling.
Han J; Zhang L; Guo H; Wysham WZ; Roque DR; Willson AK; Sheng X; Zhou C; Bae-Jump VL
Gynecol Oncol; 2015 Sep; 138(3):668-75. PubMed ID: 26135947
[TBL] [Abstract][Full Text] [Related]
25. Atractylenolide II induces cell cycle arrest and apoptosis in breast cancer cells through ER pathway.
Dou S; Yang C; Zou D; Da W; Masood M; Adlat S; Baima YJ; Nasser MI; Li B; Jiang N
Pak J Pharm Sci; 2021 Jul; 34(4):1449-1458. PubMed ID: 34799321
[TBL] [Abstract][Full Text] [Related]
26. Shikonin suppresses proliferation and induces apoptosis in endometrioid endometrial cancer cells via modulating
Huang C; Hu G
Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29449346
[TBL] [Abstract][Full Text] [Related]
27. Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer.
Yin Y; Kizer NT; Thaker PH; Chiappinelli KB; Trinkaus KM; Goodfellow PJ; Ma L
Int J Mol Sci; 2013 Aug; 14(8):16617-37. PubMed ID: 23941783
[TBL] [Abstract][Full Text] [Related]
28. FABP4 Regulates Cell Proliferation, Stemness, Apoptosis, and Glycolysis in Colorectal Cancer via Modulating ROS/ERK/mTOR Pathway.
Gao Y; Wang Y; Wang X; Ma J; Wei M; Li N; Zhao Z
Discov Med; 2023 Jun; 35(176):361-371. PubMed ID: 37272103
[TBL] [Abstract][Full Text] [Related]
29. Loss of AF-6/afadin induces cell invasion, suppresses the formation of glandular structures and might be a predictive marker of resistance to chemotherapy in endometrial cancer.
Yamamoto T; Mori T; Sawada M; Matsushima H; Ito F; Akiyama M; Kitawaki J
BMC Cancer; 2015 Apr; 15():275. PubMed ID: 25879875
[TBL] [Abstract][Full Text] [Related]
30. Atractylenolide I-mediated Notch pathway inhibition attenuates gastric cancer stem cell traits.
Ma L; Mao R; Shen K; Zheng Y; Li Y; Liu J; Ni L
Biochem Biophys Res Commun; 2014 Jul; 450(1):353-9. PubMed ID: 24944018
[TBL] [Abstract][Full Text] [Related]
31. m
Ruan P; Wang S; Yang C; Huang X; Sun P; Tan A
Cell Biol Toxicol; 2023 Aug; 39(4):1611-1626. PubMed ID: 35971034
[TBL] [Abstract][Full Text] [Related]
32. Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
Huang HL; Lin TW; Huang YL; Huang RL
Bioorg Med Chem Lett; 2016 Apr; 26(8):1905-9. PubMed ID: 26988300
[TBL] [Abstract][Full Text] [Related]
33. Variant
Malki L; Sarig O; Romano MT; Méchin MC; Peled A; Pavlovsky M; Warshauer E; Samuelov L; Uwakwe L; Briskin V; Mohamad J; Gat A; Isakov O; Rabinowitz T; Shomron N; Adir N; Simon M; McMichael A; Dlova NC; Betz RC; Sprecher E
N Engl J Med; 2019 Feb; 380(9):833-841. PubMed ID: 30763140
[TBL] [Abstract][Full Text] [Related]
34. Repression of PDK1- and LncRNA HOTAIR-Mediated EZH2 Gene Expression Contributes to the Enhancement of Atractylenolide 1 and Erlotinib in the Inhibition of Human Lung Cancer Cells.
Xiao Q; Zheng F; Tang Q; Wu JJ; Xie J; Huang HD; Yang XB; Hann SS
Cell Physiol Biochem; 2018; 49(4):1615-1632. PubMed ID: 30223276
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway.
Dong P; Xiong Y; Konno Y; Ihira K; Kobayashi N; Yue J; Watari H
J Exp Clin Cancer Res; 2021 Jun; 40(1):216. PubMed ID: 34174908
[TBL] [Abstract][Full Text] [Related]
36. Anti-Tumor Effects of Atractylenolide-I on Human Ovarian Cancer Cells.
Long F; Wang T; Jia P; Wang H; Qing Y; Xiong T; He M; Wang X
Med Sci Monit; 2017 Jan; 23():571-579. PubMed ID: 28141785
[TBL] [Abstract][Full Text] [Related]
37. Suppression of synuclein gamma inhibits the movability of endometrial carcinoma cells by PI3K/AKT/ERK signaling pathway.
Ni M; Zhao Y; Wang X
Genes Genomics; 2021 Jun; 43(6):633-641. PubMed ID: 33788083
[TBL] [Abstract][Full Text] [Related]
38. Atractylenolide II Induces Apoptosis of Prostate Cancer Cells through Regulation of AR and JAK2/STAT3 Signaling Pathways.
Wang J; Nasser MI; Adlat S; Ming Jiang M; Jiang N; Gao L
Molecules; 2018 Dec; 23(12):. PubMed ID: 30545141
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of lncRNA CCAT2 inhibits endometrial cancer cells growth and metastasis via sponging miR-216b.
Xie P; Cao H; Li Y; Wang J; Cui Z
Cancer Biomark; 2017 Dec; 21(1):123-133. PubMed ID: 29036788
[TBL] [Abstract][Full Text] [Related]
40. Cyr61 suppresses growth of human endometrial cancer cells.
Chien W; Kumagai T; Miller CW; Desmond JC; Frank JM; Said JW; Koeffler HP
J Biol Chem; 2004 Dec; 279(51):53087-96. PubMed ID: 15471875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
